Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry

2013 ESC guidelines on the management of stable coronary artery disease

(2013)   EUROPEAN HEART JOURNAL

Target cardiovascular risk rather than cholesterol concentration

(2013) H. M. Krumholz   BMJ-British Medical Journal

An International Model to Predict Recurrent Cardiovascular Disease

(2012) Peter W.F. Wilson et al.   AMERICAN JOURNAL OF MEDICINE

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

(2012) Stephan D. Fihn et al.   CIRCULATION

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry

(2012) Ph Gabriel Steg et al.   EUROPEAN HEART JOURNAL

Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease

(2012) Roberto Ferrari et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure

(2012) Gianluigi Savarese et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease

(2012) Ph. Gabriel Steg et al.   PLoS One

Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease

(2011) Anthony S. Kim et al.   CIRCULATION

National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants

(2011) Farshad Farzadfar et al.   LANCET

National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants

(2011) Goodarz Danaei et al.   LANCET

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

(2011) Salim Yusuf et al.   LANCET

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

(2011) Mariel M Finucane et al.   LANCET

Heart rate: a forgotten link in coronary artery disease?

(2011) Kim M. Fox et al.   Nature Reviews Cardiology

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

(2010) Komelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

(2010) Deepak L. Bhatt et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heart rate management in coronary artery disease: the CLARIFY registry

(2009) P. G. Steg   EUROPEAN HEART JOURNAL SUPPLEMENTS

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET